Bonnie M Davis

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 1 EPO patent. Top assignees: Synaptec Development LLC, Other. Active years: 1987-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bonnie M Davis. Retrieved from https://idiyas.com/inventor/bonnie-m-davis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 80.0

CIPO Patents = 4

EPO Patents = 1 (Patent Applications = 7)

Average Co-Inventor Count = 1.3

ph-index = 4

Forward Citations = 69(Granted Patents)

Location History:

Huntington, NY (US) (1987 - 2001)
Syosset, NY (US) (2001 - 2011)
Palm Beach Gardens, FL (US) (2020 - 2022)

Company Filing History:

2 out of 2

Synaptec Development LLC

patents

8 out of 834,570

Other

patents

Years Active: 1987-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11219627 - Clearance of amyloid beta (2022-01-11),

2. 10561665 - Treatment of autism (2020-02-18),

3. 7939522 - Dosage formulations for acetylcholinesterase inhibitors (2011-05-10),

4. 6670356 - Analogs of galanthamine and lycoramine as modulators of nicotinic receptors (2003-12-30),

5. 6569848 - Compounds for the treatment of alzheimer's disease (2003-05-27),

6. 6319919 - Galanthamine derivatives for treatment of alzheimer's disease (2001-11-20),

7. 6268358 - Compounds for the treatment of Alzheimer's disease (2001-07-31),

8. 6150354 - Compounds for the treatment of Alzheimer's disease (2000-11-21),

9. 5585375 - Method for alleviating jet lag (1996-12-17),

10. 4663318 - Method of treating Alzheimer's disease (1987-05-05),

Title: The Innovative Contributions of Bonnie M. Davis

Introduction

Bonnie M. Davis is a prominent inventor based in Syosset, NY (US). She has made significant contributions to the field of medical research, particularly in the treatment of neurological disorders. With a total of 10 patents to her name, her work has the potential to impact many lives.

Latest Patents

Among her latest patents is a groundbreaking method for the clearance of amyloid beta, which is crucial in the study of Alzheimer's disease. This patent involves the use of analogs of a specific compound that may help in reducing amyloid beta levels in the brain. Another notable patent addresses the treatment of Autism Spectrum Disorders (ASD). This invention proposes the use of a galanthamine analog, where various chemical modifications are made to enhance its efficacy in treating ASD.

Career Highlights

Throughout her career, Bonnie has worked with various companies, including Synaptec Development LLC. Her innovative approaches and dedication to research have established her as a key figure in her field.

Collaborations

Bonnie has collaborated with esteemed colleagues such as Madeleine M. Joullie and Joanne Berger-Sweeney. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Bonnie M. Davis exemplifies the spirit of innovation in the medical field. Her patents and collaborative efforts continue to pave the way for advancements in treatment options for neurological disorders.

Profile summary based on public USPTO records.